Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
Status:
Completed
Trial end date:
2013-01-24
Target enrollment:
Participant gender:
Summary
This study is a 2-year open label extension study to collect long term efficacy and safety
data from patients who have completed the 24-weeks of study drug dosing in CL0600-020.